OABI

OABI

USD

OmniAb Inc. Common Stock

$1.700-0.050 (-2.857%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.750

Haut

$1.750

Bas

$1.690

Volume

0.87M

Fondamentaux de l'Entreprise

Capitalisation Boursière

214.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.12M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.22Actuel $1.700Haut $4.96

Actualités Connexes

BusinessWire

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program

Voir plus
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")),

Voir plus
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
BusinessWire

OmniAb Announces Two New Appointments to its Board of Directors

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology OmniAb, Inc. (NASDAQ:OABI) today announced the appointments of Philip J.

Voir plus
OmniAb Announces Two New Appointments to its Board of Directors

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.